Bacillus Calmette–Guérin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer

Bacillus Calmette–Guérin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer

BackgroundBacillus Calmette–Guérin (BCG) is currently the most effective intravesical therapy for non-muscle-invasive bladder cancer (NMIBC) as it can prevent disease recurrence and progression and lower mortality. However, the response rates to BCG vary widely and are dependent on a multitude of fa...

Full description

Bibliographic Details
Main Authors: Fei Su, Ming Liu, Wei Zhang, Min Tang, Jinsong Zhang, Hexin Li, Lihui Zou, Rui Zhang, Yudong Liu, Lin Li, Jie Ma, Yaqun Zhang, Meng Chen, Fei Xiao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Oncology
Subjects:
Bacillus Calmette–Guérin
non-muscle-invasive bladder cancer
immune checkpoint
tumor microenvironment
neoantigen
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.842182/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.842182/full

Similar Items